ReviewPharmaceutics2021
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas.
Taku Fujimura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewPharmaceutics2021
Taku Fujimura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.